Company Quick10K Filing
Fabrinet
10-Q 2021-03-26 Filed 2021-05-04
10-Q 2020-12-25 Filed 2021-02-02
10-Q 2020-09-25 Filed 2020-11-03
10-K 2020-06-26 Filed 2020-08-18
10-Q 2020-03-27 Filed 2020-05-05
10-Q 2019-12-27 Filed 2020-02-04
10-Q 2019-09-27 Filed 2019-11-05
10-K 2019-06-28 Filed 2019-08-20
10-Q 2019-03-29 Filed 2019-05-07
10-Q 2018-12-28 Filed 2019-02-05
10-Q 2018-09-28 Filed 2018-11-06
10-K 2018-06-29 Filed 2018-08-22
10-Q 2018-03-30 Filed 2018-05-08
10-Q 2017-12-29 Filed 2018-02-07
10-Q 2017-09-29 Filed 2017-11-07
10-K 2017-06-30 Filed 2017-08-23
10-Q 2017-03-31 Filed 2017-05-09
10-Q 2016-12-30 Filed 2017-02-07
10-Q 2016-09-30 Filed 2016-11-09
10-K 2016-06-24 Filed 2016-08-17
10-Q 2016-03-25 Filed 2016-05-03
10-Q 2015-12-25 Filed 2016-02-02
10-Q 2015-09-25 Filed 2015-11-03
10-K 2015-06-26 Filed 2015-08-19
10-Q 2015-03-27 Filed 2015-05-05
10-Q 2014-12-26 Filed 2015-02-03
10-Q 2014-09-26 Filed 2014-11-05
10-K 2014-06-27 Filed 2014-10-16
10-Q 2014-03-28 Filed 2014-05-06
10-Q 2013-12-27 Filed 2014-02-04
10-Q 2013-09-27 Filed 2013-11-05
10-K 2013-06-28 Filed 2013-08-16
10-Q 2013-03-29 Filed 2013-05-03
10-Q 2012-12-28 Filed 2013-02-05
10-K 2012-06-29 Filed 2012-08-28
10-Q 2012-03-30 Filed 2012-05-09
10-Q 2011-12-30 Filed 2012-02-08
10-Q 2011-09-30 Filed 2011-11-09
10-K 2011-06-24 Filed 2011-08-31
10-Q 2011-03-25 Filed 2011-05-04
10-Q 2010-12-24 Filed 2011-02-02
10-Q 2010-09-24 Filed 2010-11-03
10-K 2010-06-25 Filed 2010-09-08
8-K 2021-02-01
8-K 2020-12-10
8-K 2020-11-02
8-K 2020-08-11
8-K 2020-05-04
8-K 2020-02-01
8-K 2019-12-12
8-K 2019-11-04
8-K 2019-08-20
8-K 2019-08-19
8-K 2019-08-14
8-K 2019-05-01
8-K 2019-02-26
8-K 2019-02-04
8-K 2018-12-13
8-K 2018-08-14
8-K 2018-06-15
8-K 2018-06-04
8-K 2018-05-03
8-K 2018-02-05
8-K 2018-01-09

Fabrinet Financials

FN Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2011-09-302011-12-302012-03-302012-06-292012-09-302012-12-282013-03-292013-06-282013-09-272013-12-272014-03-282014-06-272014-09-262014-12-262015-03-272015-06-262015-09-252015-12-252016-03-252016-06-242016-09-302016-12-302017-03-312017-06-302017-09-292017-12-292018-03-302018-06-292018-09-282018-12-282019-03-292019-06-282019-09-27
Cash1321121251161151281571501641802342332451121291139513112814310686137137115138146161220231166188198
Accounts Receivable12298118128138131123118126122118101108104120135140147172196213241251264275259244247259262265261274
Inventory1071039910311110094899597108125129128127131143141150181205214225239255239240258278278285294322
PP&E83889616198989817097979916798106134223144159160276206214216339218223222364217212209382212
Assets4564134534614774714894654905045685655896016456736887247698569019461,0051,0331,0451,0381,0551,0881,1481,1761,2111,2551,290
Accounts Payable865775869274747790881029510299103115118115146172180187210215204182193220249248256258252
Long-Term Debt393634312926242261
Liabilities137126211211209185180140144139153138150151181194204217238302316326356352337316319347382374382392399
Stockholders' Equity318287243251268286309325346365415427440450464479484506531554585620649682707722736741766802829863891
Income Statement ($MM)2011-09-302011-12-302012-03-302012-06-292012-09-302012-12-282013-03-292013-06-282013-09-272013-12-272014-03-282014-06-272014-09-262014-12-262015-03-272015-06-262015-09-252015-12-252016-03-252016-06-242016-09-302016-12-302017-03-312017-06-302017-09-292017-12-292018-03-302018-06-292018-09-282018-12-282019-03-292019-06-282019-09-27
Revenue18697139143159167156160172195168160189210189206216233251276332351367370357337332345377403399405399
Cost of Revenue16388124128141166139143153172150142169186168182190205220243292308323326317300295306337358352359353
Gross Profit23915151821161719231718212122252628313440434445403737394046474746
R&D
SG&A75756675777791210111214121216181715161312171413141416
Tax1-2-0-012101-111111111222221221-121112
Net Income16-33-46716792115191548101191113220212023252227211921232832293326
Cash Flow ($MM)2011-09-302011-12-302012-03-302012-06-292012-09-302012-12-282013-03-292013-06-282013-09-272013-12-272014-03-282014-06-272014-09-262014-12-262015-03-272015-06-262015-09-252015-12-252016-03-252016-06-242016-09-302016-12-302017-03-312017-06-302017-09-292017-12-292018-03-302018-06-292018-09-282018-12-282019-03-292019-06-282019-09-27
Cash Operating10-1910261233-3181922816151012519186-1214111-340533536423
Cash Investing-8-12-8-9-43-3-2-1-335-4-1-146-22-26-201-16-4-47-373-10-12-9-2837-92-1912
Cash Financing31111-2-2-2-2-2-21-2-5-3-129-2-116-5131007-4-7-9-16-13-8-1-4